Autopsy report · NCT02439008

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

“Lack of patient enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 3 years 6 months before it stopped.
• 28 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Centre Oscar Lambret

Sponsor type

University, hospital or other

Conditions

Carcinoma, Hepatocellular; Colorectal Neoplasms; Melanoma; Kidney Neoplasms

Interventions

Blood samples collection before radiotherapy; Blood samples collection during radiotherapy; Blood samples collection after radiotherapy; Radiotherapy

Participants

28

Sites

1

Countries

France

Trials that died the same way

• Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
  “Inadequate patient enrollment” (93% match in meaning)
• Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
  “Insufficient patient enrollment.” (88% match in meaning)
• Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
  “No further patient enrollment” (85% match in meaning)
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
  “Lack of enrollment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.